Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol

INTRODUCTION: Children who are HIV-exposed uninfected (HEU), that is, children who do not acquire HIV infection despite being born to mothers with HIV, have a higher risk of mortality, infectious morbidity and growth deficits than children who are HIV-unexposed uninfected (HUU). Prior research has f...

Descripción completa

Detalles Bibliográficos
Autores principales: Shivakoti, Rupak, Slogrove, Amy L, Laughton, Barbara, Shafiq, Mehr, Schoeman, Elisma, Glashoff, Richard H, Leu, Cheng-Shiun, Wang, Shuang, Bode, Lars, Aldrovandi, Grace, Kuhn, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809215/
https://www.ncbi.nlm.nih.gov/pubmed/36585139
http://dx.doi.org/10.1136/bmjopen-2022-069116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809215/
https://www.ncbi.nlm.nih.gov/pubmed/36585139
http://dx.doi.org/10.1136/bmjopen-2022-069116

Ejemplares similares